CIK 0001820190 · <br>Emerging growth company
Scilex Holding Co
Sign in to watch- Ticker
- SCLX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 516-4310
- Business address
- 960 SAN ANTONIO ROAD, PALO ALTO, CA, 94303
- Former names
- Scilex Holding Company/DE, Vickers Vantage Corp. I
Securities
- SCLX Common Stock Nasdaq
- SCLXW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-03 | SCLX Stock Acquisition JV LLC 10% owner | Other disposition | −500,000 | 958,263 | ||
| 2026-04-17 | Ma Stephen Hoi CFO, COO and Secretary | Purchase · Warrant (right to buy) | +650,000 | $0.15 | $100K | 650,000 |
| 2026-04-17 | Ji Henry Exec Chair, CEO and President | Sale · Warrant (right to buy) | −650,000 | $0.15 | $100K | 2,600,000 |
| 2026-04-16 | Ji Henry Exec Chair, CEO and President | Purchase · Warrant (right to buy) | +3,250,000 | $0.15 | $500K | 3,250,000 |
| 2025-12-30 | Scilex Holding Co 10% owner | Sale | −9,657,300 | $0.54 | $5.2M | 244,445,260 |
| 2025-12-29 | Scilex Holding Co 10% owner | Sale | −7,310,984 | $0.66 | $4.8M | 254,102,560 |
| 2025-12-26 | Scilex Holding Co 10% owner | Sale | −3,689,016 | $0.75 | $2.8M | 261,413,544 |
| 2025-10-08 | Wu Yue Alexander Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-10-08 | Ma Stephen Hoi CFO and COO | Grant or award · Incentive Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2025-10-08 | Chun Jay Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-10-08 | Ji Henry CEO and President | Grant or award · Incentive Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2025-10-08 | Followwill Dorman Director | Grant or award · Nonstatutory Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-01-21 | SCLX Stock Acquisition JV LLC 10% owner | Other disposition | −3,250,000 | 51,039,214 | ||
| 2025-01-16 | SCLX Stock Acquisition JV LLC 10% owner | Other disposition | −779,371 | 54,289,214 | ||
| 2025-01-02 | SCLX Stock Acquisition JV LLC 10% owner | Other disposition | −5,000,000 | 55,068,585 | ||
| 2024-12-18 | SHAH JAISIM See Remarks | Purchase | +30,000 | $0.46 | $14K | 139,333 |
| 2024-12-16 | Chun Jay Director | Grant or award · Nonstatutory Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2024-12-16 | Followwill Dorman Director | Grant or award · Nonstatutory Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2024-12-16 | Wu Yue Alexander Director | Grant or award · Nonstatutory Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2024-10-31 | Ji Henry Executive Chairperson | Purchase | +8,888 | $0.94 | $8K | 320,161 |
Page 1 of 4 · 75 trades